Prescribing patterns for dyspepsia in primary care: A prospective study of selected general practitioners

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 889-895

  Bodger, K ^a   Daly, M J ^a   Heatley, R V ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DYSPEPSIA; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0029802179     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.107278000.x     Document Type: Article

References (30)

1. Bodger K, Daly MJ, Heatley RV, Williams DRR. Clinical economics review : Gastroenterology. Aliment Pharmacol Ther 1996; 10: 55-60.
2. Barber N. What constitutes good prescribing? Br Med J 1995; 310: 923-5.
3. House of Commons Health Committee. Priority setting in the NHS: the NHS drugs budget. London: HMSO, 1994.
4. Freemantle N, Henry D, Maynard A, Torrance G. Promoting cost-effective prescribing. Br Med J 1995: 310: 955-6.
5. Department of Health. Statistics of prescriptions dispensed in the Family Health Services Authorities: England 1982-1992. Statistical Bulletin, 1993.
6. Ryder SD, O'Reilly S, Miller RJ, Ross J, Jacyna MR, Levi AJ. Longterm acid suppressing treatment in general practice. Br Med J 1994: 308: 827-30.
7. Roberts SJ, Bateman DN. Prescribing of antacids and ulcer-healing drugs in primary care in the north of England. Aliment Pharmacol Ther 1995: 9: 137-43.
8. Heading RC. Definitions of dyspepsia. Scand J Gastroenterol 1991: 26(Suppl. 182): 1-6.
9. Jones R. Clinical economics review: gastrointestinal problems in primary care. Aliment Pharmacol Ther 1996; 10: 233-9.
10. Bradley C, Kendall R. Clinical Guide to Practice Prescribing. London: GCN. 1994
11. Goodson JD, Richter JM, Lane RS, Beckett TP, Pingree RG. Empirical antacids and reassurance for acute dyspepsia. J Gen Intern Med 1986; 1(2): 90-3.
12. De Dombal FT. Patterns of pain in gastrointestinal disease. In: Misiewicz JJ, Pounder RE, Venebles CW, eds. Diseases of the Gut and Pancreas, 1st edn. Oxford, UK: Blackwell Scientific Publications, 1987: 26-40.
13. Jones RH, Bosanquet N, Johnson NJ, Chong Su-Lin. Cost-effective management strategies for acid-peptic disorders. Br J Med Econ 1994; 7:99-114.
14. Heatley RV. Editorial: Open access upper gastrointestinal endoscopy. Br Med J 1993: 306: 1224.
15. Williams B, Luckas M, Ellingham JHM, Dain A, Wicks ACB. Do young patients with dyspepsia need investigation. Lancet 1988; ii: 1349-51.
16. Health and Public Policy Committee American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985; 102: 266-9.
17. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-16.
18. Jones R. Evaluating upper abdominal pain. In : Gastrointestinal Problems in General Practice. New York: Oxford University Press, 1993: 43-46.
19. Talley NJ, McNeil D, Piper DW. Descriminant value of dyspeptic symptoms: a study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulcer, and cholelithiasis. Gut 1987: 28: 40-6.
20. Adami HO, Agenas I, Gustavsson S, Loof L, Nyberg A, Nyren O. The clinical diagnosis of 'gastritis'. Scand J Gastroenterol 1984; 19: 216-9.
21. Nyren O, Adami HO, Bates S, Bergstrom R, Gustavsson S. Absence of therapeutic benefit from antacids or cimetidme for non-ulcer dyspepsia. New Engl J Med 1986: 314: 339-43.
22. Halter F, Miazzi B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia - the results of a double blind, randomised, Swiss multicentre study. Scand J Gastroenterol 1994: 29: 618-21.
23. Hungin APS, Thomas PR, Bramble MG, et al. What happens to patients following open access gastroscopy ? An outcome study from general practice. Br J Gen Prac 1994: 44: 519-21.
24. NIH, Consensus Conference - Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272(1): 65-9.
25. Powell KU, Bell GD, Bolton GH, et al. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med 1994; 87: 283-90.
26. Heatley RV. H. pylori infection: how relevant is it clinically? Hospital Update 1995; 21: 119-24.
27. Talley NJ. Non-ulcer dyspepsia: myths and realities. Aliment Pharmacol Ther 1991; 5(Suppl. 1): 145-62.
28. Krasner N. Should acid-related disorders be treated with a proton pump inhibitor prior to endoscopic referral? Proceedings of a satellite meeting of the American Gastroenterology Association (New Orleans). Surrey, UK: Reed Healthcare Communications, 1994: 17-8.
29. Hampton JR. Practice variations, appropriateness and decision-analysis. Q J Med 1995; 88: 365-7.
30. Bodger K, Heatley RV. How to rationalise dyspepsia. costs. Management in General Practice 1995: March Issue; 15: 21-3.